Sana Biotechnology, Inc. SANA 深 滬
等待開盤 10-28 09:30:00 美东时间
5.25
-0.340
-6.08%
華盛通- 最 高5.70
- 今 開5.60
- 成交量 466.24万股
- 最 低 5.12
- 昨 收 5.59
- 總市值 11.87亿
- 52周最高 7.30
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.26
- 委 比 19.90%
- 總股本 2.26亿
- 歷史最高 44.60
- 量 比 0.81
- 振 幅 10.38%
- 歷史最低 1.26
- 每 手 1
- 風險率 0.97%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股牛股 | 奥麦罗制药隔夜暴涨154.2%！与诺和诺德达成重要战略合作；AI服务供应商VERI涨53.7%
奥麦罗制药隔夜暴涨154.2%！与诺和诺德达成重要战略合作；AI服务供应商VERI涨53.7%，预订量激增及Q3业绩好于预期>>
10-16 15:09
Sana Biotech Stock — The Next '100-Bagger'?
Sana Biotech stock soars after outspoken stock promoter Eric Jackson names it as his latest potential "100-bagger."
10-16 00:15
Morgan Stanley, T1 Energy, Bunge Global, Bank of America And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones index gaining around 300 points on ...
10-15 22:47
Sana Biotech surges as Eric Jackson calls it a 100-bagger
Shares of Sana Biotechnology (NASDAQ:SANA) climbed ~24% in the morning hours on Wednesday, triggering several trading halts after Canadian hedge fund manager Eric Jackson said that he is long the stoc...
10-15 22:37
美股大行评级 | 217美元！花旗上调阿里巴巴目标价；多家机构集体上调麦克森、美光科技等目标价
今日重点评级关注：Ascendiant Capital：维持Maison Solutions"买入"评级，目标价从4美元升至4.25美元；瑞穗：维持MBX Biosciences"跑赢大市"评级，目标价从38美元升至56美元
09-25 09:52
Wedbush Initiates Coverage On Sana Biotechnology with Outperform Rating, Announces Price Target of $5
Wedbush analyst Martin Fan initiates coverage on Sana Biotechnology (NASDAQ:SANA) with a Outperform rating and announces Price Target of $5.
09-24 21:28
快速构建3D世界 华硕RTX 5070显卡提供高端性能！
对于3D创作者们来说，在传统工作流中，建模师必须构建占位模型、低精度资产来填充3D场景，优化核心资产以完成场景。之后，还需要优化、细化并最终完成视觉效果。且原型...
09-19 10:51
Sana Biotechnology Board Member Resigns Effective August 29
Sana Biotechnology ( ($SANA) ) has issued an update. On August 28, 2025, Mary A...
08-30 04:28
医疗板块回暖+中报营收利润双高增，归创通桥（2190.HK）凭什么领跑创新械企？
2025年以来，沉寂已久的港股医药行业迎来强势反弹。富途显示，今年恒生医疗保健指数累计涨幅已突破100%，不仅如同一记强心针点燃市场热情，更引发市场对行业走势的...
08-27 11:40
Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares
Sana Biotechnology, Inc. announced the completion of a stock sale, issuing 3,358,208 shares at $3.35 per share, raising approximately $86.3 million before expenses. Morgan Stanley, Goldman Sachs, BofA Securities, and TD Cowen acted as joint book-running managers. The offering followed the exercise of underwriters' option post an August 8 public offering. SEC filings and prospectus details were provided, with copies available from the listed firms...
08-20 20:05
